Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Anti-Pegaspargase, Anti-Calaspargase Pegol , and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4

Reuven J Schore, MD, Meenakshi Devidas, PhD, Archie Bleyer, MD, Gregory Reaman, MD, Claudia Lebedinsky, MD, Hui Zhang, MS, Herwig Koppensteiner, PhD, Mignon L. Loh, MD, Elizabeth Raetz, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Anne Angiolillo, MD

Blood (2016) 128 (22): 3965.

https://doi.org/10.1182/blood.V128.22.3965.3965

Published: 2016

Journal Articles

Genome-Wide Association Study Identifies Germline Polymorphisms Associated with Relapse of Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 878.

https://doi.org/10.1182/blood.V120.21.878.878

Published: 2012

Journal Articles

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Wanda Salzer, MD, Barbara Asselin, MD, Jeffrey Supko, PhD, Meenakshi Devidas, PhD, Nicole Kaiser, RPh, Paul V. Plourde, MD, Naomi Winick, MD, Gregory Reaman, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen Hunger, MD

Blood (2010) 116 (21): 2134.

https://doi.org/10.1182/blood.V116.21.2134.2134

Published: 2010

Journal Articles

Selective and Titratable Effects On AML Genome Wide Methylation Patterning, Transcription and Clonogenicity Using Very Low Concentrations of 5-Aza-2'deoxycytidine.

Elisabeth Heuston, Jason E. Farrar, MD, Timothy Triche, M.D., Ph.D., Jonathan Buckley, Poul Sorensen, M.D., Ph.D., C. Patrick Reynolds, Gregory Reaman, MD, Vasan Yegnasubramanian, M.D., Ph.D., Robert J. Arceci, MD, PhD

Blood (2009) 114 (22): 2385.

https://doi.org/10.1182/blood.V114.22.2385.2385

Published: 2009

Journal Articles

Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project.

Blood (2009) 114 (22): 704.

https://doi.org/10.1182/blood.V114.22.704.704

Published: 2009

Journal Articles

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Richard C. Harvey, PhD, I-Ming Chen, MS, Kerem Ar, MS, Stephen P. Hunger, MD, Mignon Loh, MD, Eric C. Larsen, MD, Meenakshi Devidas, PhD, Elizabeth Raetz, MD, Gregory Reaman, MD, William L. Carroll, MD, Naomi Winick, MD, Malcolm Smith, MD, PhD, Kevin K Dobbin, PhD, Cheryl L. Willman, MD

Blood (2008) 112 (11): 2256.

https://doi.org/10.1182/blood.V112.11.2256.2256

Published: 2008

Journal Articles

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Blood (2008) 112 (11): 427.

https://doi.org/10.1182/blood.V112.11.427.427

Published: 2008

Journal Articles

Genetically Defined Racial Differences Underlie Risk of Relapse in Childhood Acute Lymphoblastic Leukemia

Jun J. Yang, PhD, Wenjian Yang, PhD, Cheng Cheng, Ph.D., Meenakshi Devidas, PhD, Xueyuan Cao, Dario Campana, MD, PhD, Michael J. Borowitz, MD, PhD, Cheryl L. Willman, MD, William Paul Bowman, Gregory Reaman, MD, William L. Carroll, MD, Stephen P. Hunger, MD, William E. Evans, Pharm.D., Ching-Hon Pui, M.D., Mary V. Relling, Pharm.D.

Blood (2008) 112 (11): 14.

https://doi.org/10.1182/blood.V112.11.14.14

Published: 2008

Journal Articles

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Cheryl L. Willman, MD, Huining Kang, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Charles Mullighan, MD, James R. Downing, MD, Mary V. Relling, PharmD, Jinghui Zhang, PhD, Daniela Gerhard, PhD, Malcolm Smith, MD, PhD, Kevin K. Dobbin, PhD, Gregory Reaman, MD, Stephen Hunger, MD

Blood (2008) 112 (11): sci-8.

https://doi.org/10.1182/blood.V112.11.sci-8.sci-8

Published: 2008

Journal Articles

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Richard C. Harvey, PhD, George S. Davidson, Xuefei Wang, PhD, Kevin K. Dobbin, PhD, Edward J. Bedrick, PhD, Carla S. Wilson, MD, PhD, Susan R. Atlas, PhD, Huining Kang, PhD, I-Ming Chen, DVM, Stephen P. Hunger, MD, Meenakshi Devidas, PhD, William L. Carroll, MD, Paul Bowman, MD, Bruce Camitta, MD, Gregory Reaman, MD, Cheryl L. Willman, MD

Blood (2007) 110 (11): 1430.

https://doi.org/10.1182/blood.V110.11.1430.1430

Published: 2007

NARROW

Genome-Wide Association Study Identifies Germline Polymorphisms Associated with Relapse of Childhood Acute Lymphoblastic Leukemia

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Selective and Titratable Effects On AML Genome Wide Methylation Patterning, Transcription and Clonogenicity Using Very Low Concentrations of 5-Aza-2'deoxycytidine.

Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project.

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Genetically Defined Racial Differences Underlie Risk of Relapse in Childhood Acute Lymphoblastic Leukemia

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only